rtPA in acute ischemic stroke: European perspective

Neurology

Volumn 49, Issue 5 SUPPL., 1997, Pages

  Hacke, Werner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ARTICLE; BLOOD CLOT LYSIS; DOSE CALCULATION; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; INJURY SCALE; INTERNATIONAL COOPERATION; PRIORITY JOURNAL; RATING SCALE; STROKE;

EID: 0030699323     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.49.5_suppl_4.s60     Document Type: Article

References (2)

1. Hacke W, Kaste M, Fieschi C, et al., for the ECASS Group. Safety and efficacy of intravenous thrombolysis with a recombinant tissue plasminogen activator in the treatment of acute hemispheric stroke. JAMA 1995;274:1017-1025.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.